Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy Subjects

Intravenous belimumab is approved for the treatment of systemic lupus erythematosus; subcutaneous self‐administration would enable greater patient access. This study assessed relative bioavailability, tolerability, and safety of 1 subcutaneous dose of self‐administered belimumab by healthy subjects...

Descripción completa

Detalles Bibliográficos
Autores principales: Struemper, Herbert, Murtaugh, Thomas, Gilbert, Jane, Barton, Matthew E., Fire, Joseph, Groark, James, Fox, Norma Lynn, Roth, David, Gordon, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063175/
https://www.ncbi.nlm.nih.gov/pubmed/27163500
http://dx.doi.org/10.1002/cpdd.219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063175/
https://www.ncbi.nlm.nih.gov/pubmed/27163500
http://dx.doi.org/10.1002/cpdd.219

Ejemplares similares